Bioorganic Research Institute, Suntory Foundation for Life Sciences (SUNBOR), 8-1-1 Seikadai, Seika, Soraku, Kyoto, 619-0284, Japan.
Research Institute, Suntory Global Innovation Center Ltd (SIC), 8-1-1 Seikadai, Seika, Soraku, Kyoto, 619-0284, Japan.
Nat Commun. 2017 Dec 18;8(1):2155. doi: 10.1038/s41467-017-02053-7.
(+)-Sesamin, (+)-sesamolin, and (+)-sesaminol glucosides are phenylpropanoid-derived specialized metabolites called lignans, and are rich in sesame (Sesamum indicum) seed. Despite their renowned anti-oxidative and health-promoting properties, the biosynthesis of (+)-sesamolin and (+)-sesaminol remained largely elusive. Here we show that (+)-sesamolin deficiency in sesame is genetically associated with the deletion of four C-terminal amino acids (Del4C) in a P450 enzyme CYP92B14 that constitutes a novel clade separate from sesamin synthase CYP81Q1. Recombinant CYP92B14 converts (+)-sesamin to (+)-sesamolin and, unexpectedly, (+)-sesaminol through an oxygenation scheme designated as oxidative rearrangement of α-oxy-substituted aryl groups (ORA). Intriguingly, CYP92B14 also generates (+)-sesaminol through direct oxygenation of the aromatic ring. The activity of CYP92B14 is enhanced when co-expressed with CYP81Q1, implying functional coordination of CYP81Q1 with CYP92B14. The discovery of CYP92B14 not only uncovers the last steps in sesame lignan biosynthesis but highlights the remarkable catalytic plasticity of P450s that contributes to metabolic diversity in nature.
(+)-芝麻素、(+)-芝麻林素和(+)-芝麻素醇葡萄糖苷是苯丙素衍生的特殊代谢物,称为木脂素,在芝麻(Sesamum indicum)种子中含量丰富。尽管它们具有众所周知的抗氧化和促进健康的特性,但(+)-芝麻林素和(+)-芝麻素醇的生物合成在很大程度上仍然难以捉摸。在这里,我们表明芝麻中(+)-芝麻林素的缺乏与 CYP92B14 中四个 C 末端氨基酸(Del4C)的缺失有关,CYP92B14 是一种新型的 P450 酶,与芝麻素合酶 CYP81Q1 分开。重组 CYP92B14 将(+)-芝麻素转化为(+)-芝麻林素,并且出人意料地通过一种称为α-氧基取代芳基的氧化重排(ORA)的氧合方案转化为(+)-芝麻素醇。有趣的是,CYP92B14 还通过直接氧化芳环生成(+)-芝麻素醇。当与 CYP81Q1 共表达时,CYP92B14 的活性增强,这意味着 CYP81Q1 与 CYP92B14 之间存在功能协调。CYP92B14 的发现不仅揭示了芝麻木质素生物合成的最后几步,而且突出了 P450 显著的催化可塑性,这有助于自然界中的代谢多样性。